Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Today in Medicine.
Plus Therapeutics Announces $1.6 Million Advance Payment from CPRIT
GlobeNewswire, Inc.
·
July 23, 2025
HOUSTON, July 23, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS)...
Topflight Pharma Development Veteran Joins Synendos
GlobeNewswire, Inc.
·
July 15, 2025
BASEL, Switzerland, July 15, 2025 (GLOBE NEWSWIRE) -- Synendos Therapeutics (“Synendos”), the clinical-stage biotechnology company developing breakthrough therapies for neuropsychiatric disorders, announced today that it has named Dr. George...
Announcing exciting new potential non-pharma emotional support for kids with autism, ADHD
EIN Presswire
·
July 14, 2025
Florida Study Explores Non-Invasive Tech for Emotional Support in Kids with Autism and ADHD BOCA RATON, FL, UNITED STATES, July 14, 2025 /EINPresswire.com/ -- What if the most meaningful breakthrough in youth mental health didn’t come in the...
Harris Dental Ensures Judgment-Free Dental Services for Local Patients - DELETED
EIN Presswire
·
July 24, 2025
Harris Dental Offers Compassionate, Judgment-Free Care for Local Patients BARNSTABLE, MA, UNITED STATES, July 23, 2025 /EINPresswire.com/ -- Harris Dental is proud to offer judgment-free dental care designed to support local patients with...
Scientist Dr. Akiko Iwasaki Joins SPEAR Study Group to Investigate Monoclonal Antibodies for Long COVID and COVID-19 Post-Vaccination Syndrome
GlobeNewswire, Inc.
·
July 23, 2025
WALTHAM, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), today announced the addition of Akiko Iwasaki, Ph.D., Professor of Immunobiology at Yale School of Medicine, to the SPEAR (Spike Protein Elimination and Recovery)...
60 Degrees Pharmaceuticals to Submit MUMS (Minor Use/Minor Species) Designation Request to FDA for Tafenoquine for Acute Canine Babesiosis in 2025
GlobeNewswire, Inc.
·
July 14, 2025
Data from three independent clinical studies demonstrate utility of tafenoquine to treat acute canine babesiosis WASHINGTON, July 14, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees” or the “Company”),...
Total Orthopedics and Sports Medicine Expands Multi-Specialty Spine and Orthopedic Care in New York
GlobeNewswire, Inc.
·
July 14, 2025
Photo Courtesy of Total Orthopedics and Sports Medicine BROOKLYN, N.Y., July 14, 2025 (GLOBE NEWSWIRE) -- Total Orthopedics and Sports Medicine, a leading multi-specialty orthopedic practice with 14 locations across the region, continues to grow...
Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule
GlobeNewswire, Inc.
·
July 15, 2025
SAN JOSE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through transformative urology solutions, today announced that...
4TEEN4 Doses First Patient in Phase 1b/2a Trial of Procizumab, a Monoclonal Antibody Targeting the Biological Driver of Shock
GlobeNewswire, Inc.
·
July 23, 2025
The trial will evaluate safety, dosing, and efficacy in patients with cardiogenic shock Hennigsdorf/ Berlin, July 23, 2025 – 4TEEN4 Pharmaceuticals GmbH today announced that the first patient has been dosed in a Phase 1b/2a PROCARD1 clinical trial...
Shaping the Future
New York State Office of the Governor
·
July 23, 2025
Governor Kathy Hochul and Secretary Hillary Rodham Clinton today announced the launch of the New York School (NYS) x #HalfTheStory Teen Tech Council, a groundbreaking statewide initiative placing teens at the forefront of educational innovation....
AMYLYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Amylyx Pharmaceuticals, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire, Inc.
·
July 14, 2025
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Amylyx (AMLX) To Contact Him Directly To Discuss Their Options If you purchased or acquired common stock in Amylyx Pharmaceuticals, Inc....
Acetonitrile Market Grows with Pharmaceutical Analysis,EV Batteries & Sustainable Solvent Innovations|DataM Intelligence
EIN Presswire
·
July 14, 2025
The acetonitrile market is projected to grow at 4.7% CAGR, fueled by pharma analysis, battery production, and sustainable bio‑based and recovery innovations. NEW YORK, NY, UNITED STATES, July 14, 2025 /EINPresswire.com/ -- Market Overview :...
Ascentage Pharma Announces Pricing of Top-Up Placement
GlobeNewswire, Inc.
·
July 14, 2025
ROCKVILLE, Md. and SUZHOU, China, July 14, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855) (“Ascentage” or the “Company”), a global biopharmaceutical company dedicated to addressing unmet medical needs...
HHS, FDA and USDA Address the Health Risks of Ultra-Processed Foods
U.S. Food and Drug Administration
·
July 23, 2025
For Immediate Release: July 23, 2025 Under the leadership of the U.S. Department of Health and Human Services Secretary Robert F. Kennedy, Jr. and the U.S. Department of Agriculture Secretary Brooke L. Rollins, the U.S. Food and Drug...
Recludix Pharma Announces Strengthening of Leadership Team, Including Promotion of Dr. Brian Hodous to Chief Scientific Officer
GlobeNewswire, Inc.
·
July 14, 2025
--Brian Hodous, Ph.D., promoted to chief scientific officer -- Vivek Kadambi, Ph.D., joins Recludix as senior vice president of non-clinical sciences and CMC -- Kristin Polsenski, M.B.A., expands role to include chief of staff to the CEO SAN...
Investors in Rocket Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before August 11, 2025 to Discuss Your Rights – RCKT
GlobeNewswire, Inc.
·
July 14, 2025
NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. ("Rocket" or the "Company") (NASDAQ: RCKT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover...
HYTN Secures Cannabis Drug Licence, Advancing Prescription Drug Pathway for Cannabinoid-Based Medicines
GlobeNewswire, Inc.
·
July 14, 2025
VANCOUVER, British Columbia, July 14, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a leader in pharmaceutical-grade cannabis manufacturing, is pleased to announce it has received...
Ovid Therapeutics to Participate in the BTIG Virtual Biotech Conference
GlobeNewswire, Inc.
·
July 23, 2025
NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to developing small molecule medicines for brain conditions with significant unmet need, announced today that the Company’s...
Borvo EVAC™ System Demonstrates 100% Success Rate in Chronic Subdural Hematoma Clinical Cases Validated Across 5 Medical Centers
GlobeNewswire, Inc.
·
July 14, 2025
MOUNTAIN VIEW, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- Borvo Medical, a neurosurgical medtech startup and a portfolio company of NeuroTechnology Investors (NTI), today announced a 100% success rate across five medical centers using the...
Medical Supplierz Announces Strategic Partnerships with Leading Healthcare Brands
EIN Presswire
·
July 10, 2025
KUWAIT, KUWAIT, July 10, 2025 /EINPresswire.com/ -- Medical Supplierz, a digital B2B marketplace for medical equipment and supplies, has announced new partnerships with a select group of leading healthcare brands. These collaborations aim to...